Yayınlanmış 1 Ocak 2017
| Sürüm v1
Dergi makalesi
Açık
Epigallocatechin-3-gallate reduces the proliferation of benign prostatic hyperplasia cells via regulation of focal adhesions
Oluşturanlar
- 1. Uludag Univ, Fac Arts & Sci, Dept Mol Biol & Genet, TR-16059 Bursa, Turkey
- 2. Manisa Celal Bayar Univ, Dept Med Biol, Fac Med, TR-45030 Manisa, Turkey
Açıklama
Aims: Benign prostatic hyperplasia (BPH) is the most common urological disease that is characterized by the excessive growth of prostatic epithelial and stromal cells. Pharmacological therapy for BPH has limited use due to the many side effects so there is a need for new agents including natural compounds such as epigallocatechin-3-gallate (EGCG). This study was undertaken to assess the role of EGCG, suppressing the formation of BPH by reducing inflammation and oxidative stress, in cytoskeleton organization and ECM interactions via focal adhesions.
Dosyalar
bib-56ae7c64-6a4a-4f84-8608-43797fefef71.txt
Dosyalar
(204 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:1d518fbb663e00636b554453649f6487
|
204 Bytes | Ön İzleme İndir |